Last CNY19.96 CNY
Change Today -0.86 / -4.13%
Volume 3.6M
300147 On Other Exchanges
As of 3:00 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

xiangxue pharmaceutical co-a (300147) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/25/14 - CNY25.06
52 Week Low
12/3/13 - CNY13.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for XIANGXUE PHARMACEUTICAL CO-A (300147)

Related News

No related news articles were found.

xiangxue pharmaceutical co-a (300147) Related Businessweek News

No Related Businessweek News Found

xiangxue pharmaceutical co-a (300147) Details

Xiangxue Pharmaceutical Co., Ltd. is engaged in the development, production, and distribution of Chinese patent medicines in China and internationally. The company offers Chinese medicines, western medicines, medical devices, and health products, as well as beverages. It also offers antiviral oral liquids for the prevention and treatment of cold under the brand name of Xiangxue; and indigowoad root granules. The company offers its products in the form of tablets, capsules, granules, oral liquids, aerosols, and others. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.

Founded in 1997

xiangxue pharmaceutical co-a (300147) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

xiangxue pharmaceutical co-a (300147) Key Developments

Xiangxue Pharmaceutical Co., Ltd. Announces 2013 Final Distribution Plan Payable on July 14, 2014

Xiangxue Pharmaceutical Co., Ltd. announced final distribution plan to be implemented (A shares) of cash dividend per 10 shares (tax included) of CNY 1.60. Payable on July 14, 2014 with record date of July 11, 2014 and Ex-date of July 14, 2014.

Xiangxue Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Fiscal Year of 2013

Xiangxue Pharmaceutical Co., Ltd. announced that at its annual general meeting was held on May 23, 2014, the shareholders approved the cash dividend of CNY 1.60 (tax included) per 10 shares for the fiscal year of 2013.

Xiangxue Pharmaceutical Co., Ltd., Annual General Meeting, May 23, 2014

Xiangxue Pharmaceutical Co., Ltd., Annual General Meeting, May 23, 2014., at 10:00 China Standard Time. Agenda: To consider the 2013 work report of the board of directors; to consider the 2013 work report of the supervisory committee; to consider the 2013 financial resolution report; to consider the 2013 annual report and its summary; to consider the 2013 profit distribution plan; to consider the mandate to the board to handle matters in relation to the 2013 profit distribution plan and amendments to the articles of association of the company; to consider the remuneration matters for directors; to consider the application for comprehensive credit line to banks and handling bank loan; to consider the bank loan guarantee for subsidiaries; to consider the result of 2013 continuing connected transactions and 2014 estimated continuing connected transactions; and to consider the reappointment of audit firm.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300147:CH CNY19.96 CNY -0.86

300147 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300147.
View Industry Companies

Industry Analysis


Industry Average

Valuation 300147 Industry Range
Price/Earnings 60.4x
Price/Sales 7.6x
Price/Book 6.5x
Price/Cash Flow 61.5x
TEV/Sales 6.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XIANGXUE PHARMACEUTICAL CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at